We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Editor's Correspondence |

Amiodarone-Induced Hyperthyroidism

Bernard Goichot, MD, PhD; Fabienne Grunenberger, MD; Jean-Louis Schlienger, MD
Arch Intern Med. 2001;161(2):295. doi:.
Text Size: A A A
Published online


In their "Practical Guidelines for Clinicians Who Treat Patients With Amiodarone," Goldschlager et al1 missed some important points on the effect of amiodarone on thyroid function. First, it seems important to recall that amiodarone inhibits the conversion of thyroxine to triiodothyronine, resulting in slightly but abnormally increased free thyroxine levels contrasting with normal thyrotropin concentrations in the majority of patients treated with amiodarone despite clinical euthyroidism.2 Therefore, screening for thyroid dysfunction (reference 1, Table 2) requires only thyrotropin measurement in amiodarone-treated patients. Second, in Goldschlager and colleagues' Table 1, the incidence of hyperthyroidism is much lower than that of hypothyroidism in these patients. This is true in North America, not in Europe or other countries that have a suboptimal iodine supply. In Europe, amiodarone-induced hyperthyroidism (AIH) is more frequent than hypothyroidism, occurring in up to 10% of patients treated with amiodarone.3 In our experience, AIH accounts for 50% of severe hyperthyroidism in subjects 70 years of age and older.4 The diagnosis of hyperthyroidism may be difficult in patients taking amiodarone, who often lack the cardiac signs of thyrotoxicosis because of the inhibitory effect of desethylamiodarone on the binding of triiodothyronine on the cardiac thyroid hormone α1-receptor.5 Third, Goldschlager and colleagues stated that "hyperthyroidism due to amiodarone is usually inflammatory thyroiditis." Although the mechanisms of AIH are complex and have not been completely elucidated,2,6,7 in our experience, as in that of other investigators, only about half of patients with AIH have biologic, ultrasonographic, or histologic signs of thyroiditis (referred to by some authors as type II AIH) and have a favorable outcome with steroid therapy. Iodide excess is the other major mechanism of AIH (type I); however, differentiation between the 2 mechanisms is difficult in most cases.6 Potassium perchlorate inhibits iodide accumulation in the thyroid gland by acting, among other mechanisms, on the sodium/iodide symporter of the thyroid follicle. Perchlorate is an effective treatment of iodine-induced hyperthyroidism in some patients, with few adverse effects when a low dosage (<1 g/d) is used.7 Thus, in our opinion, thyroidectomy must be considered only in patients whose AIH does not respond to a combination therapy consisting of carbimazole (or methimazole or 6-propyl-2-thiouracil), corticosteroids, and perchlorate. Clinicians have to remember that the discontinuation of amiodarone therapy is sufficient to allow recovery of AIH in about 50% of the patients.5 In some patients in whom amiodarone therapy can be discontinued but who may need it again, preventive radioiodine treatment (after normalization of iodide uptake) is probably the best solution.

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections
PubMed Articles